Medicine

Psychedelics amplify brain connectivity through serotonin receptors, study suggests

How the science connects

Brain connectivityPsychedelicsSerotonin receptor

AI Insight

Psychedelics such as psilocybin, LSD, DMT, and mescaline work by amplifying brain connectivity through serotonin receptors, fundamentally altering perception, thought, and consciousness. While these substances are being investigated for treating depression, anxiety, and addiction, scientific understanding of their basic mechanisms of action lags behind their therapeutic applications. Researchers emphasize that understanding how psychedelics fundamentally change brain function is essential to making sense of their therapeutic effects.


A deeper understanding of how psychedelics alter brain connectivity and consciousness could lead to more targeted and effective treatments for mental health disorders. This basic mechanistic knowledge is crucial for developing evidence-based therapeutic protocols and ensuring safe clinical applications.


Understand the Science

Brain connectivity 5 articles Explore Concept → Psychedelics Concept coming soon Serotonin receptor Concept coming soon

Psychedelics like psilocybin (from magic mushrooms), LSD, DMT and mescaline profoundly alter how we perceive, feel and think. After decades of neglect, they are again the subject of serious scientific inquiry, largely because of their promise for treating depression, anxiety, addiction and other conditions. But this therapeutic promise has run ahead of a more basic understanding: While a great deal of attention has gone to whether psychedelics help treat mental disorders, far less has gone to what they actually do in a general sense—the fundamental way they change perception, thought and consciousness. Only by understanding these basic mechanisms can we ever make sense of the therapeutic effects.

Source: Psychedelics amplify brain connectivity through serotonin receptors, study suggests